Biomind Labs Inc. (BMNDF)

Biomind Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0	0	0.02	0.03	2.27
Cash & Short-Term Investments	0	0	0.02	0.03	2.27
Cash Growth	-75.51%	-99.39%	-7.23%	-98.85%	-
Prepaid Expenses	-	-	-	0.02	0.17
Other Current Assets	-	0.02	0.02	-	-
Total Current Assets	0	0.02	0.05	0.04	2.44
Property, Plant & Equipment	-	0.02	0.03	0.04	0.09
Total Assets	0	0.04	0.07	0.09	2.53
Accounts Payable	0.39	0.27	0.56	0.33	0.29
Short-Term Debt	0.73	0.67	0.74	-	-
Current Portion of Leases	-	-	-	0.01	0.04
Other Current Liabilities	0.62	0.4	0.21	-	-
Total Current Liabilities	1.74	1.34	1.51	0.34	0.32
Long-Term Leases	-	-	-	-	0.01
Total Liabilities	1.74	1.34	1.51	0.34	0.33
Common Stock	11.45	11.45	11.1	11.1	11.1
Retained Earnings	-15.74	-14.88	-14.62	-13.43	-10.45
Comprehensive Income & Other	2.55	2.14	2.09	2.08	1.54
Shareholders' Equity	-1.74	-1.3	-1.43	-0.25	2.19
Total Liabilities & Equity	0	0.04	0.07	0.09	2.53
Total Debt	0.73	0.67	0.74	0.01	0.05
Net Cash (Debt)	-0.73	-0.67	-0.72	0.02	2.23
Net Cash Growth	-	-	-	-99.19%	-
Net Cash Per Share	-0.01	-0.01	-0.01	0.00	0.03
Filing Date Shares Outstanding	77.57	77.57	74.76	74.76	74.76
Total Common Shares Outstanding	77.57	77.57	74.76	74.76	74.76
Working Capital	-1.74	-1.32	-1.46	-0.29	2.11
Book Value Per Share	-0.02	-0.02	-0.02	-0.00	0.03
Tangible Book Value	-1.74	-1.3	-1.43	-0.25	2.19
Tangible Book Value Per Share	-0.02	-0.02	-0.02	-0.00	0.03
Machinery	-	0.04	0.04	0.04	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.